Abbasnia, M., Mosleh, N., Dadras, H., Rezaeianzadeh, G., & Boroomand, Z. (2020). Effect of different herbal preparations on experimental viral respiratory complex of broilers: clinical, pathological and ciliary activity aspects. Journal of Herbmed Pharmacology, 9(3): 277-285.
Alexander, D.J. (2003). Newcastle disease and other avian paramyxoviridae infections. In: Diseases of Poultry, ed. Saif Y.M., Barnes H.J., Glisson, J.R., Fadly A.M., McDougald L.R., & Swayne D.E. 11th ed., pp. 64–87. Iowa State University Press, Ames, IA.
Benne, N., van Duijn, J., Kuiper, J., Jiskoot, W., & Slütter, B (2016). Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. Journal of Controlled Release. 234, p: 124-134.
Brewer, M., Pollock, K.G., Tetley, L., & Russell, D.G. (2004). Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles, Journal of Immunology, 173, 6143-6150.
Choi, J.G., Lee, Y.J., Kim, Y.J., Lee, E.K., Jeong, O.M., Sung, H.W., Kim, J.H., & Kwon J.H. (2008). An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea. Journal of Veterinary Science, 9: 67-74.
Fenner, F. Smallpox: emergence, global spread, and eradication (1993). History and Philosophy of the Life Sciences. 15(3): 397-420; PMID: 7529932.
Hassan, K.E., Ali A., Shany, S.A.S., & El-Kady, M.F. (2017). Experimental co-infection of infectious bronchitis and low pathogenic avian influenza H9N2 viruses in commercial broiler chickens. Research in Veterinary Science, 115:356–362.
Iyer, V., Cayatte C., Guzman, B., Schneider-Ohrum, K., Matuszak, R., Snell, A., Manohar Rajani, G., McCarthy, M.P., & Muralidhara, B. (2015). Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants. Human Vaccines & Immunotherapeutics 11(7): 1853-1864.
Jackwood, M., & Wit, S.D. (2020). Infectious Bronchitis. In: Disease of Poultry. Edited by Swayne D.E., Boulianne M., Logue C.M., McDougald L.R., Nair V., and Suarez D.L. Diseases of Poultry, 14th edition, PP: 167-181.
Leitner, G., Dan Heller, E., & Friedman, A. (1989). Sex-related differences in immune response and survival rate of broiler chickens. Veterinary Immunology and Immunopathology, 21 (3–4): 249-260.
Mant, A., Chinnery, F., Elliott, T., & Williams, A.P. (2012). The pathway of cross presentation is influenced by the particle size of phagocytosed antigen. Immunology, 136: 163-175.
Mayahi, M., SefiAbad Shapouri, M.R., Jafary, R., & Khosravi Farsani, M. (2015). Isolation and molecular diagnostic of pigeon paramyxovirus-1 from suspected pigeons to Newcastle disease in Ahvaz, Iran. Iranian Veterinary Journal, 11(2):102-112.
Mottram, P.L., Leong, D., Crimeen-Irwin, B., Gloster, S., Xiang, S.D., Meanger, J., Ghildyal, R., Vardaxis, N. & Plebanski, M. (2007). Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Molecular Pharmacology, 4: 73-84.
Naomi, B., Janine van, D., Johan, K., Wim, J. & Bram, (2016). S. Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. Journal of Controlled Release, 234:124-34. DOI: 10.1016/j.jconrel.2016.05.033
Ott, G., Barchfeld, G.L., Chernoff, D., Radhakrishnan, R.,Van Hoogevest, P., & Van Nest, G. (1995). Design and evaluation of a safe and potent adjuvant for human vaccines. Pharmaceutical Biotechnology, 6, p: 277-96; PMID: 7551221; http://dx.doi.org/10.1007/978-1- 4615-1823-5-10.
Peacock, T.H.P., James, J., Sealy, J.E., & Iqbal, M. (2019). A global perspective on H9N2 avian influenza virus. Viruses, 11(7). Pii: E 620.doi:10.3390/v11070620.
Rodrigues, C.M.C., & Plotkin, S.A. (2020). Impact of Vaccines; Health, Economic and Social Perspectives. Front. Microbiology, 11: 1526.
Seydoux, E., Rothen-Rutishauser, B., Nita, I.M., Balog, S., Gazdhar, A., Stumbles, P.A., Petri- Fink, A., Blank, F., & von Garnier, C. (2014). Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation, International Journal of Nanomedicine, 9: 3885-3902.
Shengqing, Y., Shinya, K., Otsuki, K., Ito, H., & Ito, T. (2002). Isolation of myxoviruses from migratory waterfowls in San-in district, western Japan in winters of 1997–2000. Journal of Veterinary Medical Science, 64: 1049-1052.
Shima, F., Uto, T., Akagi, T., Baba, M., & Akashi, M. (2013). Size effect of amphiphilic poly (γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo. Acta Biomaterialia, 9: 8894-8901.
Silva, A.L., Rosalia, R.A., Varypataki, E., Sibuea, S., Ossendorp, F., & Jiskoot, W. (2015). Poly-(lactic-co- glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation. Vaccine, 33, 847-854.
Teresa, C., Giraldo, C., López-Abán J., Muro A., Patarroyo, M.A., & Román, R. M. (2021). Nanovaccines against Animal Pathogens: The Latest Findings. Vaccines (Basel) 9(9): 988. Doi: 10.3390/vaccines9090988.
Vogel, F.R., Caillet, C., Kusters, I.C., & Haensler, J. (2009). Emulsion based adjuvants for influenza vaccines. Expert Review of Vaccines, 8(4): 483-92; PMID: 19348563; http:// dx.doi.org/10.1586/erv.09.5.
Zhao, L., Zhu, Z., Ma, L., & Li, Y. (2020). O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying. International Journal of Nanomedicine, 15: 2071-2083. Doi: 10.2147/IJN.S232677.
